Champlain Investment Partners, LLC Vericel Corp Transaction History
Champlain Investment Partners, LLC
- $15.1 Billion
- Q4 2024
A detailed history of Champlain Investment Partners, LLC transactions in Vericel Corp stock. As of the latest transaction made, Champlain Investment Partners, LLC holds 623,440 shares of VCEL stock, worth $32.4 Million. This represents 0.23% of its overall portfolio holdings.
Number of Shares
623,440Holding current value
$32.4 Million% of portfolio
0.23%Shares
1 transactions
Others Institutions Holding VCEL
# of Institutions
291Shares Held
50.7MCall Options Held
98.2KPut Options Held
135K-
Black Rock Inc. New York, NY8.06MShares$419 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.49MShares$181 Million0.0% of portfolio
-
Brown Capital Management LLC Baltimore, MD3.24MShares$168 Million4.21% of portfolio
-
State Street Corp Boston, MA2.4MShares$125 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA2.24MShares$116 Million0.02% of portfolio
About Vericel Corp
- Ticker VCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,178,000
- Market Cap $2.45B
- Description
- Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...